Celcuity Inc. (CELC) vs Pulse Biosciences, Inc. (PLSE)
A side-by-side comparison of Celcuity Inc. and Pulse Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELC
Celcuity Inc.
$71.71HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
PLSE
Pulse Biosciences, Inc.
$49.70HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — CELC vs PLSE
growth of $100 · dividends reinvested · last 9yCELC +415.2% (+20.0%/yr)PLSE +247.8% (+14.9%/yr)CELC compounded faster over this window
CELC PLSE
CELC vs PLSE: by the numbers
- •CELC is the larger company ($3.50B vs $3.44B market cap).
- •Both run net losses; CELC's is the smaller (0.00% vs -6755.78% net margin).
Metrics side by side
Valuation
| Metric | CELC | PLSE |
|---|---|---|
| P/S ratio | N/A | 2902.43 |
| P/B ratio | N/A | 34.57 |
Profitability
| Metric | CELC | PLSE |
|---|---|---|
| Gross margin | 0.00% | -360.00% |
| Operating margin | 0.00% | -21982.57% |
| Net margin | 0.00% | -6755.78% |
| ROE | N/A | -80.46% |
| ROIC | -28.15% | -79.40% |
Growth (annualized)
| Metric | CELC | PLSE |
|---|---|---|
| Total return CAGR (5Y) | 34.40% | 19.76% |
Frequently asked
- How have CELC and PLSE total returns compared?
- Over the past 5 years, CELC delivered 34.40% and PLSE delivered 19.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Celcuity ROEPulse Biosciences ROECelcuity operating marginPulse Biosciences operating marginCelcuity revenue growthPulse Biosciences revenue growthCelcuity free cash flowPulse Biosciences free cash flow
Celcuity & Pulse Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.